A Comparative Study Between Carbohydrate-deficient Transferrin and Gamma-glutamyltransferase for the Diagnosis of Excessive Drinking in a Liver Unit
Overview
Affiliations
Aim: To compare the efficacy of carbohydrate-deficient transferrin and gamma-glutamyltransferase for the diagnosis of excessive alcohol intake in patients admitted in a liver unit.
Methods: The 346 patients were divided into three groups of alcoholics: 57 patients (31 men, 26 women) with a normal liver, 77 patients (51 men, 26 women) with non-cirrhotic alcoholic liver disease, and 61 patients (43 men, 18 women) with alcoholic cirrhosis; and three groups of non-alcoholics: 35 abstainers (21 men, 14 women), and 58 healthy blood donors (26 men, 32 women), and 58 patients (32 men, 26 women) who had a non-alcoholic liver disease. Carbohydrate-deficient transferrin and gamma-glutamyltransferase were measured at admission using commercially available kits.
Results: Carbohydrate-deficient transferrin was more sensitive than gamma-glutamyltransferase in patients without alcoholic liver disease, in both men (85 vs 54%) and women (64 vs 36%). Carbohydrate-deficient transferrin sensitivity decreased slightly but not significantly according to the severity of the liver disease in men and women. The sensitivity of gamma-glutamyltransferase which was low in men and women without alcoholic liver disease, improved in groups with moderate or severe alcoholic liver disease: not less than 80% in men and up to 100% in women. The specificity of carbohydrate-deficient transferrin in patients with non-alcoholic liver disease was consistently higher than that of gamma-glutamyltransferase (80% vs 60%).
Conclusions: In liver units, carbohydrate-deficient transferrin can help to identify excessive drinkers without liver disease with a higher efficacy than that of gamma-glutamyltransferase; carbohydrate-deficient transferrin can also be used to distinguish between alcoholics with moderate liver disease and patients with non-alcoholic liver diseases.
Niu X, Zhu L, Xu Y, Zhang M, Hao Y, Ma L BMC Public Health. 2023; 23(1):859.
PMID: 37170239 PMC: 10173666. DOI: 10.1186/s12889-023-15749-x.
Focus on alcoholic liver disease: from nosography to treatment.
Streba L, Vere C, Streba C, Ciurea M World J Gastroenterol. 2014; 20(25):8040-7.
PMID: 25009375 PMC: 4081674. DOI: 10.3748/wjg.v20.i25.8040.
Evaluation of the oxidative stress in chronic alcoholics.
Singh M, Gupta S, Singhal U, Pandey R, Aggarwal S J Clin Diagn Res. 2013; 7(8):1568-71.
PMID: 24086841 PMC: 3782898. DOI: 10.7860/JCDR/2013/5596.3210.
Utility of a new model to diagnose an alcohol basis for steatohepatitis.
Dunn W, Angulo P, Sanderson S, Jamil L, Stadheim L, Rosen C Gastroenterology. 2006; 131(4):1057-63.
PMID: 17030176 PMC: 2483536. DOI: 10.1053/j.gastro.2006.08.020.